Mandate

Vinge advises BHG Group in connection with the acquisition of Hafa Bathroom Group

Vinge is advising BHG Group AB (publ) in connection with its acquisition of 94% of the shares in Hafa Bathroom Group.

Hafa Bathroom Group is Sweden’s largest privately-owned bathroom company with a market leading online platform. The company primarily sells products under the three trademarks of Hafa, NORO and Westerbergs and conducts operations in all of the Nordic countries and in the Baltic Region. During 2020, the turnover amounted to approximately MSEK 200 with good profitability.

BHG Group is the largest online actor within consumer trading in the Nordic Region and the largest actor in Europe within home improvement, which includes both Do It Yourself and Home Furnishing. BHG Group’s e-trading operations employ approximately 2,000 people and include more than 100 online destinations and 70 showrooms. The head office is situated in Malmö with operations in most European countries. BHG Group is listed on Nasdaq Stockholm.

The transaction is subject to customary approvals by public authorities.

Vinge’s team consisted of Kristian Ford together with, among others, Niklas Törnell, Lena Westberg, Julia Ahlqvist, Karin Gynnerstedt, Johanne Örnfeldt Svensson, Philip Åberg and Pär Remnelid (competition law).

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026